BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moutinho-Ribeiro P, Macedo G, Melo SA. Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble? Front Endocrinol (Lausanne) 2018;9:779. [PMID: 30671023 DOI: 10.3389/fendo.2018.00779] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Duan B, Hu X, Fan M, Xiong X, Han L, Wang Z, Tong D, Liu L, Wang X, Li W, Yang J, Huang C. RNA-Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer. Proteomics Clin Appl 2019;13:e1900048. [PMID: 31207145 DOI: 10.1002/prca.201900048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Van Audenaerde JR, Marcq E, von Scheidt B, Davey AS, Oliver AJ, De Waele J, Quatannens D, Van Loenhout J, Pauwels P, Roeyen G, Lardon F, Slaney CY, Peeters M, Kershaw MH, Darcy PK, Smits EL. Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment. Clin Transl Immunology. 2020;9:e1165. [PMID: 32821382 DOI: 10.1002/cti2.1165] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
3 Zhang TN, Yin RH, Wang LW. The prognostic and predictive value of the albumin-bilirubin score in advanced pancreatic cancer. Medicine (Baltimore) 2020;99:e20654. [PMID: 32664063 DOI: 10.1097/MD.0000000000020654] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Zhang YB, Fei HX, Guo J, Zhang XJ, Wu SL, Zhong LL. Dauricine suppresses the growth of pancreatic cancer in vivo by modulating the Hedgehog signaling pathway. Oncol Lett 2019;18:4403-14. [PMID: 31611949 DOI: 10.3892/ol.2019.10790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Moccia M, Caratelli V, Cinti S, Pede B, Avitabile C, Saviano M, Imbriani AL, Moscone D, Arduini F. Paper-based electrochemical peptide nucleic acid (PNA) biosensor for detection of miRNA-492: a pancreatic ductal adenocarcinoma biomarker. Biosens Bioelectron 2020;165:112371. [PMID: 32729503 DOI: 10.1016/j.bios.2020.112371] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
6 Seyhan AA, Carini C. Are innovation and new technologies in precision medicine paving a new era in patients centric care? J Transl Med. 2019;17:114. [PMID: 30953518 DOI: 10.1186/s12967-019-1864-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 17.0] [Reference Citation Analysis]
7 Zhang WH, Wang WQ, Han X, Gao HL, Li TJ, Xu SS, Li S, Xu HX, Li H, Ye LY, Lin X, Wu CT, Long J, Yu XJ, Liu L. Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective. Comput Struct Biotechnol J 2020;18:3606-14. [PMID: 33304458 DOI: 10.1016/j.csbj.2020.11.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Heydari R, Abdollahpour-Alitappeh M, Shekari F, Meyfour A. Emerging Role of Extracellular Vesicles in Biomarking the Gastrointestinal Diseases. Expert Rev Mol Diagn 2021;:1-24. [PMID: 34308738 DOI: 10.1080/14737159.2021.1954909] [Reference Citation Analysis]
9 Sadighbayan D, Sadighbayan K, Khosroushahi AY, Hasanzadeh M. Recent advances on the DNA-based electrochemical biosensing of cancer biomarkers: Analytical approach. TrAC Trends in Analytical Chemistry 2019;119:115609. [DOI: 10.1016/j.trac.2019.07.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
10 Peng C, Wang J, Gao W, Huang L, Liu Y, Li X, Li Z, Yu X. Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer. Int J Med Sci 2021;18:660-71. [PMID: 33437201 DOI: 10.7150/ijms.52706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yildiz TA, Köse E, Elliott SL. MATHEMATICAL MODELING OF PANCREATIC CANCER TREATMENT WITH CANCER STEM CELLS. J Biol Syst 2021;29:799-822. [DOI: 10.1142/s0218339021500182] [Reference Citation Analysis]
12 Yee NS. Liquid Biopsy: A Biomarker-Driven Tool towards Precision Oncology. J Clin Med 2020;9:E2556. [PMID: 32784545 DOI: 10.3390/jcm9082556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Wiesmueller F, Kopke J, Aust D, Roy J, Dahl A, Pilarsky C, Grützmann R. Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer. Int J Mol Sci 2019;20:E5437. [PMID: 31683647 DOI: 10.3390/ijms20215437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Lu X, Wu Y, Cao R, Yu X, Gong J. CXCL12 secreted by pancreatic stellate cells accelerates gemcitabine resistance of pancreatic cancer by enhancing glycolytic reprogramming. Animal Cells and Systems. [DOI: 10.1080/19768354.2022.2091019] [Reference Citation Analysis]
15 Xu Z, Peng M, Zhang Z, Zeng H, Shi R, Ma X, Wang L, Liao B. Graphene-Assisted Electrochemical Sensor for Detection of Pancreatic Cancer Markers. Front Chem 2021;9:733371. [PMID: 34490213 DOI: 10.3389/fchem.2021.733371] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Shin HS, Jung SB, Park S, Dua P, Lee DK. ALPPL2 Is a Potential Diagnostic Biomarker for Pancreatic Cancer-Derived Extracellular Vesicles. Mol Ther Methods Clin Dev 2019;15:204-10. [PMID: 31687420 DOI: 10.1016/j.omtm.2019.08.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
17 Jin X, Fang R, Fan P, Zeng L, Zhang B, Lu X, Liu T. PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer. J Exp Clin Cancer Res 2019;38:463. [PMID: 31718704 DOI: 10.1186/s13046-019-1466-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
18 Tatischeff I. Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles. Int J Mol Sci 2021;22:5674. [PMID: 34073560 DOI: 10.3390/ijms22115674] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Chi Y, Xin H, Liu Z. Exosomal lncRNA UCA1 Derived From Pancreatic Stellate Cells Promotes Gemcitabine Resistance in Pancreatic Cancer via the SOCS3/EZH2 Axis. Front Oncol 2021;11:671082. [PMID: 34868904 DOI: 10.3389/fonc.2021.671082] [Reference Citation Analysis]